Location History:
- Munich, DE (1999)
- Nagoya, JP (2002)
- München, DE (2006)
Company Filing History:
2 out of 1,289 
1 out of 157 
Years Active: 1999-2006
Title: Naohito Aoki: Innovator in Nucleic Acid Technologies
Introduction
Naohito Aoki is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of nucleic acids and their applications in diagnosing and treating various diseases. With a total of 3 patents, Aoki's work has paved the way for advancements in medical research and therapeutic methods.
Latest Patents
Aoki's latest patents include innovative methods and compositions related to nucleic acids encoding BDP-1 and other polypeptides. His inventions encompass nucleic acid molecules that encode full-length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides. These patents also cover nucleic acid vectors, recombinant cells, and methods for identifying compounds that interact with these polypeptides. Furthermore, Aoki has developed methods for diagnosing abnormal conditions in organisms related to these molecules, as well as treatment and screening methods for diseases associated with PTP20 and its binding partners.
Career Highlights
Throughout his career, Naohito Aoki has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and Sugen Incorporated. His research has significantly impacted the understanding of protein tyrosine phosphatases and their roles in various biological processes.
Collaborations
Aoki has collaborated with notable scientists, including Axel Ullrich and Yeong Woong Kim. These partnerships have further enhanced the scope and impact of his research in the field of nucleic acids and related technologies.
Conclusion
Naohito Aoki's contributions to nucleic acid technologies and his innovative patents have established him as a key figure in medical research. His work continues to influence the development of diagnostic and therapeutic methods for various diseases.